Draft:Medvi


MEDVi, LLC is one of the first reported[1] companies to use artificial intelligence technology to create a "one-person unicorn business" (a solo billion-dollar business), similar to what Sam Altman had predicted.[2][3][4]

Founding

Begun in September 2024 by Matthew Gallagher with no employees and outsourcing all other non-AI services, he hired 1 employee in April 2025, then 7 more in September of 2025..[1]

Finances

The first full year of business, in 2025, had revenue and profit around $400M and $65M respectively; projected 2026 profits and revenue are ~$75M and $1.8B, repspectively..[1]

Telehealth business practices

FDA warning

Other companies in similar telehealth service platforms are Hello Cake and Lovely Meds (which have been found to use the same medical groups for business such as Open Loop Health, Beluga Health, MD Integrations, and Telegra)[5] have, along with Hims & Hers Health, have been warned by the FDA of falsely equating their compounded drugs to similar brand-name drugs that are FDA-approved, thus implying that their compounded drugs are also FDA-approved.[6][7]

AI marketing

Advertising and marketing by MEDVi shows AI images of products and patients (before-and-after weightloss)[8] but MEDVi does include a disclaimer saying ""Individuals appearing in advertisements may be actors or AI portraying doctors and are not licensed medical professionals."[6]

References

  1. ^ a b c Griffith, Erin (2 April 2026). "How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company". The New York Times. Retrieved 6 April 2026.
  2. ^ Sawers, Paul (1 February 2025). "AI agents could birth the first one-person unicorn — but at what societal cost?". TechCrunch.
  3. ^ Ohanian, Alexis. "Interview with OpenAI CEO Sam Altman by Alexis Ohanian". X.com account of Alexis Ohanian.
  4. ^ Minevich, Mark (20 August 2025). "The Billion-Dollar Company Of One Is Coming Faster Than You Think". Forbes.
  5. ^ Palmer, Katie (12 March 2026). "The FDA is targeting telehealth marketing of GLP-1 drugs. Who's prescribing them?". STAT.
  6. ^ a b Buntz, Brian (4 April 2026). "The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.'". Drug Discovery and Development. WTWH Media.
  7. ^ "MEDVi, LLC dba MEDVi - 721455 - 02/20/2026". FDA. Center for Drug Evaluation and Research. 3 March 2026.
  8. ^ Dupré, Maggie Harrison (29 May 2025). "This Sleazy GLP-1 Prescription Site Is Using Deepfaked "Before-and-After" Photos of Fake Patients, and Running Ads Showing AI-Generated Ozempic Boxes". Futurism.
Stub icon

This business-related article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.